These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 36456428)

  • 1. Clinical-radiomics predictors to identify the suitability of transarterial chemoembolization treatment in intermediate-stage hepatocellular carcinoma: A multicenter study.
    Wang DD; Zhang JF; Zhang LH; Niu M; Jiang HJ; Jia FC; Feng ST
    Hepatobiliary Pancreat Dis Int; 2023 Dec; 22(6):594-604. PubMed ID: 36456428
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Computed tomography radiomic features and clinical factors predicting the response to first transarterial chemoembolization in intermediate-stage hepatocellular carcinoma.
    Shi ZX; Li CF; Zhao LF; Sun ZQ; Cui LM; Xin YJ; Wang DQ; Kang TR; Jiang HJ
    Hepatobiliary Pancreat Dis Int; 2024 Aug; 23(4):361-369. PubMed ID: 37429785
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of a computed tomography-based radiomics nomogram for prediction of transarterial chemoembolization refractoriness in hepatocellular carcinoma.
    Niu XK; He XF
    World J Gastroenterol; 2021 Jan; 27(2):189-207. PubMed ID: 33510559
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intratumoral and peritumoral radiomics based on contrast-enhanced MRI for preoperatively predicting treatment response of transarterial chemoembolization in hepatocellular carcinoma.
    Zhao Y; Zhang J; Wang N; Xu Q; Liu Y; Liu J; Zhang Q; Zhang X; Chen A; Chen L; Sheng L; Song Q; Wang F; Guo Y; Liu A
    BMC Cancer; 2023 Oct; 23(1):1026. PubMed ID: 37875815
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radiomics analysis based on contrast-enhanced MRI for predicting short-term efficacy of drug-eluting beads transarterial chemoembolization in hepatocellular carcinoma.
    Xi Z; Ye Y; Yang Y; He Y; Song Z; Ma Q; Zeng H; Shao G
    Abdom Radiol (NY); 2024 Jul; 49(7):2387-2400. PubMed ID: 39030402
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Contrast-Enhanced CT Imaging Features Combined with Clinical Factors to Predict the Efficacy and Prognosis for Transarterial Chemoembolization of Hepatocellular Carcinoma.
    Sun Z; Shi Z; Xin Y; Zhao S; Jiang H; Li J; Li J; Jiang H
    Acad Radiol; 2023 Sep; 30 Suppl 1():S81-S91. PubMed ID: 36803649
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prediction of tumor response via a pretreatment MRI radiomics-based nomogram in HCC treated with TACE.
    Kong C; Zhao Z; Chen W; Lv X; Shu G; Ye M; Song J; Ying X; Weng Q; Weng W; Fang S; Chen M; Tu J; Ji J
    Eur Radiol; 2021 Oct; 31(10):7500-7511. PubMed ID: 33860832
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CT-based radiomics nomogram for prediction of survival after transarterial chemoembolization with drug-eluting beads in patients with hepatocellular carcinoma and portal vein tumor thrombus.
    Cheng S; Hu G; Jin Z; Wang Z; Xue H
    Eur Radiol; 2023 Dec; 33(12):8715-8726. PubMed ID: 37436507
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predicting Survival Using Pretreatment CT for Patients With Hepatocellular Carcinoma Treated With Transarterial Chemoembolization: Comparison of Models Using Radiomics.
    Kim J; Choi SJ; Lee SH; Lee HY; Park H
    AJR Am J Roentgenol; 2018 Nov; 211(5):1026-1034. PubMed ID: 30240304
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MRI-Based Radiomics: Associations With the Recurrence-Free Survival of Patients With Hepatocellular Carcinoma Treated With Conventional Transcatheter Arterial Chemoembolization.
    Song W; Yu X; Guo D; Liu H; Tang Z; Liu X; Zhou J; Zhang H; Liu Y; Liu X
    J Magn Reson Imaging; 2020 Aug; 52(2):461-473. PubMed ID: 31675174
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Radiomics Signature-Based Nomogram to Predict the Progression-Free Survival of Patients With Hepatocellular Carcinoma After Transcatheter Arterial Chemoembolization Plus Radiofrequency Ablation.
    Fang S; Lai L; Zhu J; Zheng L; Xu Y; Chen W; Wu F; Wu X; Chen M; Weng Q; Ji J; Zhao Z; Tu J
    Front Mol Biosci; 2021; 8():662366. PubMed ID: 34532340
    [No Abstract]   [Full Text] [Related]  

  • 12. Radiomics nomogram for the prediction of microvascular invasion of HCC and patients' benefit from postoperative adjuvant TACE: a multi-center study.
    Zhang K; Zhang L; Li WC; Xie SS; Cui YZ; Lin LY; Shen ZW; Zhang HM; Xia S; Ye ZX; He K; Shen W
    Eur Radiol; 2023 Dec; 33(12):8936-8947. PubMed ID: 37368104
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Accurate prediction of responses to transarterial chemoembolization for patients with hepatocellular carcinoma by using artificial intelligence in contrast-enhanced ultrasound.
    Liu D; Liu F; Xie X; Su L; Liu M; Xie X; Kuang M; Huang G; Wang Y; Zhou H; Wang K; Lin M; Tian J
    Eur Radiol; 2020 Apr; 30(4):2365-2376. PubMed ID: 31900703
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and Interpretability Analysis of Noninvasive Imaging Based on Computed Tomography in Patients with Hepatocellular Carcinoma After Initial Transarterial Chemoembolization.
    Dai Y; Liu D; Xin Y; Li Y; Wang D; He B; Zeng X; Li J; Jia F; Jiang H
    Acad Radiol; 2023 Sep; 30 Suppl 1():S61-S72. PubMed ID: 37393179
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Non-invasive assessment of response to transcatheter arterial chemoembolization for hepatocellular carcinoma with the deep neural networks-based radiomics nomogram.
    Liu Y; Liu Z; Li X; Zhou W; Lin L; Chen X
    Acta Radiol; 2024 Jun; 65(6):535-545. PubMed ID: 38489805
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preoperative CECT-based Radiomic Signature for Predicting the Response of Transarterial Chemoembolization (TACE) Therapy in Hepatocellular Carcinoma.
    Bai H; Meng S; Xiong C; Liu Z; Shi W; Ren Q; Xia W; Zhao X; Jian J; Song Y; Ni C; Gao X; Li Z
    Cardiovasc Intervent Radiol; 2022 Oct; 45(10):1524-1533. PubMed ID: 35896687
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Imaging Predictors of Survival in Patients with Single Small Hepatocellular Carcinoma Treated with Transarterial Chemoembolization.
    Park C; Kim JH; Kim PH; Kim SY; Gwon DI; Chu HH; Park M; Hur J; Kim JY; Kim DJ
    Korean J Radiol; 2021 Feb; 22(2):213-224. PubMed ID: 32901464
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Machine-learning analysis of contrast-enhanced computed tomography radiomics predicts patients with hepatocellular carcinoma who are unsuitable for initial transarterial chemoembolization monotherapy: A multicenter study.
    Jin Z; Chen L; Zhong B; Zhou H; Zhu H; Zhou H; Song J; Guo J; Zhu X; Ji J; Ni C; Teng G
    Transl Oncol; 2021 Apr; 14(4):101034. PubMed ID: 33567388
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predicting Survival Using Whole-Liver MRI Radiomics in Patients with Hepatocellular Carcinoma After TACE Refractoriness.
    Yang C; Yang HC; Luo YG; Li FT; Cong TH; Li YJ; Ye F; Li X
    Cardiovasc Intervent Radiol; 2024 Jul; 47(7):964-977. PubMed ID: 38750156
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A radiomics signature associated with underlying gene expression pattern for the prediction of prognosis and treatment response in hepatocellular carcinoma.
    Wang D; Zhang L; Sun Z; Jiang H; Zhang J
    Eur J Radiol; 2023 Oct; 167():111086. PubMed ID: 37708675
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.